Cell surface expression of HFE protein in epithelial cells, macrophages, and monocytes

Haematologica

Volumn 85, Issue 4, 2000, Pages 340-345

  Parkkila, Seppo ^a,b   Parkkila, Anna Kaisa ^a,b   Waheed, Abdul ^a   Britton, Robert S ^a   Zhou, Xiao Yan ^a   Fleming, Robert E ^a   Tomatsu, Shunji ^a   Bacon, Bruce R ^a   Sly, William S ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

Hereditary hemochromatosis; HFE; Iron; Leukocytes; Plasma membrane

Indexed keywords

HLA ANTIGEN;

ANIMAL CELL; ARTICLE; EPITHELIUM CELL; GENETIC DISORDER; HEMOCHROMATOSIS; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IRON METABOLISM; MACROPHAGE; MONOCYTE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION;

AMINO ACID SUBSTITUTION; EPITHELIAL CELLS; GENES, MHC CLASS I; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MEMBRANE PROTEINS; MONOCYTES; POINT MUTATION; STAINING AND LABELING; STOMACH;

EID: 0034118022     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Cartwright GE, Edwards CQ, Kravitz K, et al. Hereditary hemochromatosis. Phenotypic expression of the disease. N Engl J Med 1979; 301:175-9.
2. Ross CE, Muir WA, Alan BP, Graham RC, Kellermeyer RW. Hemochromatosis. Pathophysiologic and genetic considerations. Am J Clin Pathol 1975; 63: 179-91.
3. McLaren GD. Reticuloendothelial iron stores and hereditary hemochromatosis: a paradox. J Lab Clin Med 1989; 113:137-8.
4. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13:399-408.
5. Beutler E, Gelbart T, West C, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 1996; 22:187-94.
6. Jouanolle AM, Gandon G, Jézéquel P, et al. Haemochromatosis and HLA-H. Nat Genet 1996; 14:251-2.
7. Jazwinska EC, Cullen LM, Busfield F, et al. Haemochromatosis and HLA-H. Nat Genet 1996; 14:249-51.
8. Carella M, D'Ambrosio L, Totaro A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997; 60:828-32.
9. Borot N, Roth M-P, Malfroy L, et al. Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients. Immunogenetics 1997; 45:320-4.
10. Datz C, Lalloz MR, Vogel W, et al. Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis. J Hepatol 1997; 27: 773-9.
11. Sham RL, Ou C-Y, Cappuccio J, Braggins C, Dunnigan K, Phatak PD. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases. Blood Cells Mol Dis 1997; 23:314-20.
12. Beckman LE, Saha N, Spitsyn V, Van Landeghem G, Beckman L. Ethnic differences in the HFE codon 282 (Cys/Tyr) polymorphism. Hum Hered 1997; 47:263-7.
13. Feder JN, Tsuchihashi Z, Irrinki A, et al. The hemochromatosis founder mutation in HLA-H disrupts β2-microglobulin interaction and cell surface expression. J Biol Chem 1997; 272:14025-8.
14. Waheed A, Parkkila S, Zhou XY, et al. Hereditary hemochromacosis: Effects of C282Y and H63D mutations on association with β2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA 1997; 94:12384-9.
15. Zhou XY, Tomatsu S, Fleming RE, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998; 95:2492-7.
16. Levy JE, Montross LK, Cohen DE, Fleming MD, Andrews NC. The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. Blood 1999; 94:9-11.
17. Parkkila S, Waheed A, Britton RS, et al. Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci USA 1997; 94:2534-9.
18. Parkkila S, Waheed A, Britton RS, et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 1997; 94:13198-202.
19. Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1998; 95:1475-7.
20. Lebrón JA, Bennett MJ, Vaughn DE, et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 1998; 93:111-23.
21. Shah PK, Falk E, Badimon JJ, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995; 95:1565-9.
22. Leb L, Crusberg T, Fortier N, Snyder LM. Evaluation of methods using adherence to substrate and density gradient for the isolation of human monocytes. J Immunol Methods 1983; 58:309-21.
23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
24. Cattan D. Iron and mucosal intestinal macrophages. Lancet 1983; 12:106.
25. Astaldi G, Meardi G, Lisino T. The iron content of jejunal mucosa obtained by Crosby's biopsy in hemochromatosis and hemosiderosis. Blood 1966; 28:70-82.
26. Björn-Rasmussen E, Nielsen H, Hageman J, van den Dungen P. Monocyte chemotactic properties in hereditary hemochromatosis. Acta Med Scand 1986; 219: 309-13.
27. Jacobs A, Summers MR. Iron uptake and ferritin synthesis by peripheral blood leucocytes in patients with primary idiopathic haemochromatosis. Br J Haematol 1981; 49:649-52.
28. Bassett ML, Halliday JW, Powell LW. Ferritin synthesis in peripheral blood monocytes in idiopathic hemochromatosis. J Lab Clin Med 1982; 100:137-45.
29. Sizemore DJ, Bassett ML. Monocyte transferrin-iron uptake in hereditary hemochromatosis. Am J Hematol 1984; 16:347-54.
30. Björn-Rasmussen E, Hageman J, van den Dungen P, Prowit-Ksiazek A, Biberfeld P. Transferrin receptors on circulating monocytes in hereditary haemochromatosis. Scand J Haematol 1985; 34:308-11.
31. Flanagan PR, Lam D, Banerjee D, Valberg LS. Ferritin release by mononuclear cells in hereditary hemochromatosis. J Lab Clin Med 1989; 113:145-50.
32. Adams PC, Chau LA, White M, Lazarovits A. Expression of transferrin receptors on monocytes in hemochromatosis. Am J Hematol 1991; 37:247-52.
33. Cairo G, Recalcati S, Montosi G, Castrusini E, Conte D, Pietrangelo A. Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. Blood 1997; 89:2546-53.
34. Waheed A, Parkkila S, Saarnio J, et al. Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc Natl Acad Sci USA 1999; 96:1579-84.
35. Gatter KC, Brown G, Trowbridge IS, Woolston R-E, Mason DY. Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol 1983; 36:539-45.
36. Weiel JE, Adams DO, Hamilton TA. Murine monocytes express transferrin receptors: Evidence for similarity to inflammatory macrophages. Cell Immunol 1984; 88:343-9.
37. Taetle R, Honeysett JM. γ-interferon modulates human monocyte/macrophage transferrin receptor expression. Blood 1988; 71:1590-5.
38. Parmley RT, Gilbert CS, White DA, Barton JC. Ultrastructural silver enhancement of Prussian blue-reactive iron in hematopoietic and intestinal cells. J Histochem Cytochem 1988; 36:433-40.
39. Murakawa H, Bland CE, Willis WT, Dallman PR. Iron deficiency and neutrophil function: different rates of correction of the depressions in oxidative burst and myeloperoxidase activity after iron treatment. Blood 1987; 69:1464-8.
40. Bjerrum OW, Bjerrum OJ, Borregaard N. β2-microglobulin in neutrophils: an intragranular protein. J Immunol 1987; 138:3913-7.
41. Afeltra A, Caccavo D, Ferri GM, et al. Expression of lactoferrin on human granulocytes: analysis with polyclonal and monoclonal antibodies. Clin Exp Immunol 1997; 109:279-85.
42. Bastin JM, Jones M, O'Callaghan CA, Schimanski L, Mason DY, Townsend ARM. Kupffer cell staining by an HFE-specific monoclonal antibody: implications for hereditary haemochromatosis. Br J Haematol 1998; 103:931-41.
43. Koller BH, Marrack P, Kappler JW, Smithies O. Normal development of mice deficient in β2M, MHC class I proteins, and CD8+ T cells. Science 1990; 248:1227-30.
44. Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, Jaenisch R. β2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 1990; 344:742-6.
45. Rock KL, Gamble S, Rothstein L, Gramm C, Benacerraf B. Dissociation of β2-microglobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface. Cell 1991; 65:611-20.
46. Ljunggren H-G, Stam NJ, Öhlén C, et al. Empty MHC class I molecules come out in the cold. Nature 1990; 346:476-80.
47. Raulet DH. MHC class I-deficient mice. Adv Immunol 1994; 55:381-421.